SCIENTIFIC REPORT 2010 - 2011 - IOV

More documents

Recommendations

Info

Line 5 - Tumor Immunology and Innovative Therapeutic Approaches 230 Introduction 230 Workflow Project List 231 Line 6 - Quality of Life in Cancer Patients and Geriatric Oncology 232 Introduction 232 Workflow Project List 233 CLINICAL RESEARCH 235 Ethics Committee 236 Clinical Trials 237 CONTENTS 4 VENETO ONCOLOGY NETWORK 245 EDUCATION 249 Internal Education & Training 250 Post-graduate Schools 255 Meetings and Seminars 257 AWARDS 261 PUBLICATIONS 265 INDEx 305
FOREWORD FOREWORD 5
Page 1: SCIENTIFIC REPORT 2010 - 2011 ISTIT
Page 6 and 7: This volume is the third edition of
Page 9 and 10: THE INSTITUTE THE INSTITUTE 9
Page 11 and 12: Aerial view of the Busonera area TH
Page 13 and 14: Chief Officer Address THE INSTITUTE
Page 16 and 17: The IOV Governance The IOV is gover
Page 18 and 19: GENERAL DIRECTORATE Pier Carlo Muzz
Page 21 and 22: Chief Medical Officer Report CLINIC
Page 23 and 24: to interact with other IRCCS to pro
Page 25 and 26: DRG average relative weight 4,5 4,0
Page 27 and 28: Radiation treatments 1200 1000 800
Page 29 and 30: The experts of these groups meet at
Page 31 and 32: THE DEPARTMENTS THE DEPARTMENTS 31
Page 33 and 34: Department of Clinical Oncology THE
Page 35 and 36: Clinical and Research Staff Vittori
Page 37 and 38: Clinical Activity Distribution of p
Page 39 and 40: Major Ongoing Research Projects NEw
Page 41 and 42: of Ramucirumab using a double-blind
Page 43: events has been planned in order to
Page 46 and 47: Main Pubblications Clinical Oncolog
Page 48 and 49: Mission The mission of this Unit is
Page 50 and 51: Major Ongoing Research Projects iDE
Page 52: NEw ThErapEuTiC STraTEGiES iN ThE T
Page 55 and 56:
Clinical and Research Staff Antonio
Page 57 and 58:
Department of Surgery THE DEPARTMEN
Page 59 and 60:
Clinical and Research Staff Carlo C
Page 61 and 62:
Major Research Collaborations Insid
Page 64 and 65:
Main Pubblications Chief Breast Sur
Page 66 and 67:
Mission The mission of the Breast S
Page 68 and 69:
Main Pubblications Melanoma and Sof
Page 70 and 71:
Mission The Melanoma and Soft Tissu
Page 72 and 73:
National Collaborations Italian Sar
Page 74 and 75:
express bioluminescent or fluoresce
Page 76 and 77:
Diagnostic and Operative Endoscopy
Page 78 and 79:
Mission The mission of the Unit is
Page 80 and 81:
Major Ongoing Research Projects frO
Page 82 and 83:
Main Pubblications Chief Comparison
Page 85 and 86:
Mission The mission of the Unit of
Page 87 and 88:
late (occurring after the first che
Page 89 and 90:
Department of Imaging, Radiology &
Page 91 and 92:
Clinical and Research Staff Fabio P
Page 93 and 94:
Major Ongoing Research Projects Dif
Page 96 and 97:
Main Pubblications Chief Correlatio
Page 98 and 99:
Mission The Breast Imaging Unit mis
Page 100 and 101:
Regarding the new HIBRC2 study, the
Page 102 and 103:
Methods. Patient accrual, following
Page 104 and 105:
Mission and Clinical Activity The m
Page 107 and 108:
Department of Radiotherapy & Nuclea
Page 109 and 110:
Clinical and Research Staff Guido S
Page 111 and 112:
Clinical Activity The acquisition o
Page 113 and 114:
Areas of Excellence Thyroid cancer
Page 115 and 116:
Fig. 2. The thick Beryllium target,
Page 117 and 118:
field and the Nuclear Medicine Serv
Page 120 and 121:
Main Pubblications Chief Medical Ph
Page 122 and 123:
Mission To assure safe, accurate an
Page 124 and 125:
Other Programs and Future Perspecti
Page 127 and 128:
Department of Experimental, Laborat
Page 129 and 130:
Clinical and Research Staff Annaros
Page 131 and 132:
Analyses for solid tumors by year A
Page 133 and 134:
egard, the activity of some researc
Page 135 and 136:
to high-risk families; b) assessmen
Page 137 and 138:
with plasmids expressing either p16
Page 139 and 140:
The results published so far indica
Page 141 and 142:
levels of h-TERT mRNA increased wit
Page 143 and 144:
More recently, given that the real
Page 145 and 146:
aDvaNCED appliCaTiONS Of CirCulaTiN
Page 147 and 148:
the persistence of more aggressive
Page 149 and 150:
phosphokinome will be investigated
Page 151 and 152:
algorithm that takes into account t
Page 153 and 154:
samples. Except for 13q deletions,
Page 155 and 156:
Clinical and Research Staff Giusepp
Page 157 and 158:
Figure 1. the tumor of the adrenal
Page 159 and 160:
goal of this project is to use a co
Page 161 and 162:
Department of Services THE DEPARTME
Page 163 and 164:
Clinical and Research Staff Angelo
Page 165 and 166:
according to the onco-AIFA Registry
Page 168 and 169:
Main Pubblications Chief Alberto Ba
Page 170 and 171:
Mission This Unit is mainly devoted
Page 172 and 173:
Main Pubblications Chief Positive e
Page 174 and 175:
Mission The Psycho-oncology Service
Page 176 and 177:
An ad hoc intervention has therefor
Page 178 and 179:
Main Pubblications Chief Cancer pre
Page 180 and 181:
Mission The main aims of the Veneto
Page 182:
Population and Social Policies. Thi
Page 187 and 188:
Scientific Director Address THE RES
Page 189 and 190:
e transferred from the bench to bed
Page 191 and 192:
Scientific Directorate Organization
Page 193 and 194:
library Responsible: Mauro Apostoli
Page 195 and 196:
In the awareness of the difficult t
Page 197 and 198:
Research: Input and Output The rese
Page 199 and 200:
strategic focus for the Government
Page 201 and 202:
Impact Factor Trend 1000 800 600 40
Page 203 and 204:
Clinical and Research Staff Gian Lu
Page 205 and 206:
International Collaborations Emma C
Page 209 and 210:
Strategic Scientific Options THE RE
Page 211 and 212:
approaches are tested at the IOV wi
Page 213 and 214:
Thiopurine S-methyltransferase (TPM
Page 215 and 216:
of specific functional features of
Page 217 and 218:
RESEARCH ACTIVITY REPORT RESEARCH A
Page 219 and 220:
N° Prog Titolo Responsabile L01P01
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
L03P44 L03P45 L03P46 L03P47 L03P48
Page 227 and 228:
Page 229 and 230:
L04P39 Chemioterapia adiuvante in p
Page 231 and 232:
Page 233 and 234:
Progr. Titolo Responsabile L06P01 L
Page 235 and 236:
CLINICAL RESEARCH CLINICAL RESEARCH
Page 237 and 238:
Numerous phase II and III, sponsore
Page 239 and 240:
A Multicenter phase III trial to ev
Page 241 and 242:
LUNG An International multicenter r
Page 243:
A randomized, double-blind, placebo
Page 246 and 247:
Veneto Oncology Network The Istitut
Page 248 and 249:
Building a network is not a trivial
Page 250 and 251:
Internal Education & Training The I
Page 252 and 253:
La comunicazione interpersonale neg
Page 254 and 255:
Trattamento del dolore cronico nel
Page 256 and 257:
EDUCATION 256
Page 258 and 259:
Charles R M Bangham How does HTLV-1
Page 261:
AWARDS VENETO ONCOLOGY AWARDS NETWO
Page 265 and 266:
PUBLICATIONS PUBLICATIONS 265
Page 267 and 268:
carcinoma with singular bone metast
Page 269 and 270:
46 Ciccolallo L, Licitra L, Cantù
Page 271 and 272:
P, Rubeca T, Zappa M. Immunochemica
Page 273 and 274:
113 Novara G, De Marco V, Aragona M
Page 275 and 276:
4-mercaptophenol derivative designe
Page 277 and 278:
Use of a manual dermatoscope with a
Page 279 and 280:
Cancer Genetics Network, Thomassen
Page 281 and 282:
33 Cecchin D, Schiavi F, Fanti S, F
Page 283 and 284:
of diphtheria toxin A or its varian
Page 285 and 286:
17:3; 524-528; 2010 95 Lumachi F, L
Page 287 and 288:
130 Peranzoni E, Zilio S, Marigo I,
Page 289 and 290:
Surgery of the Alimentary Tract; 14
Page 291 and 292:
191 Zorzi M, Baracco S, Fedato C. L
Page 293 and 294:
ectal cancer: Pathologic results of
Page 295 and 296:
[as member of AIRTUM WG: Zambon P,
Page 297 and 298:
in laryngeal carcinoma treated with
Page 299 and 300:
G, Toland A E, Gerdes A M, Thomasse
Page 301 and 302:
european patients with central nerv
Page 303:
2011 PUBLICATIONS / Non indexed in
Page 306 and 307:
Index of Names A Alaibac Mauro 46,
Page 308 and 309:
Analytical Index A Acute Lymphoblas
Page 310:
Colophon Title: Scientific Report 2
show all

SCIENTIFIC REPORT 2010 - 2011 - IOV

Create successful ePaper yourself

Delete template?

Save as template?